Oxford Biomedica eyes UK supply boost of AstraZeneca's COVID-19 vaccine
Published
Oxford Biomedica has signed a new manufacturing agreement with a group backed by the UK government to help it scale up production of AstraZeneca's potential COVID-19 vaccine to cater to demand in the United Kingdom and Europe.
Full Article